
Ozlem Bilen MD🫀FACC
@ozlembilen2
Followers
3K
Following
6K
Media
113
Statuses
3K
Chief of Cardiology @EmoryUniversityHospital Alum@BCM@Hacettepe #cvHCM #cvVHD #echofirst #CardiacImaging Mom of 3💎
Decatur, GA
Joined September 2016
New in @JACCJournals: Cardiogenic shock in hypertrophic cardiomyopathy #cvHCM treated with mavacamten & clarithromycin. Important to understand drug-drug interactions! https://t.co/Se5NlxCvwf
3
11
39
A new multicenter evaluation of 1538 patients with obstructive #HCM treated with #mavacamten Goal: provide real-world safety outcomes (recall mavacamten is very effective so we are not covering that) - Exposure (median): 13.4 months - Median dose 5 mg - AF incidence 13% - Of
3
11
34
In symptomatic #nHCM, #mavacamten improved LV diastolic & LA function with modest LVH regression, but 1 in 5 demonstrated an #LVEF <50%, which reversed following therapy interruption. https://t.co/mA9ljpTTPF
#JACC #ESCCongress #WCCardio @DesaiMilindY
0
10
33
MAPLE-HCM Study: #Aficamten monotherapy compared to metoprolol monotherapy improves echocardiographic measures of cardiac structure and function in participants with symptomatic #oHCM
https://t.co/CWJTF0r9Jh
#ESCCongress #WCCardio #JACC #Echofirst @MasriAhmadMD @AnneDybro
1
26
87
Presented at #ESCCongress: In symptomatic obstructive hypertrophic cardiomyopathy, aficamten improved oxygen uptake and heart function and decreased symptoms more than metoprolol, with a similar incidence of adverse events. Full MAPLE-HCM phase 3 trial results:
0
21
43
Cardiology Fellowship applicants- I am looking for a new clinical research fellow for sports cardio to start July 2026! 2 yrs research, then gen cards! Apply to @EmoryMedicine Cardiology if interested! @austinjrim @JasonTsoMD #sportscards
7
67
232
1 year data on aficamten in the FOREST HCM trial are now published in JACC Journals https://t.co/iFjzRnJsrj
#CardioTwitter
0
12
41
ESC Congress LBT announced today! Delighted to present the results of the MAPLE-HCM trial in my hometown of MADRID! 🎉👏🏻🥳 Aficamten vs BB in monotherapy for obstructive HCM 🤔 Saturday 30th in Hot line session 2! Stay tunned!! ⏱️ @CNIC_CARDIO @cardiopdh @Cytokinetics
5
24
77
We presented data on 48-72 week #whyCMR cardiac structure and function remodeling on aficamten in patients with #obstructive #HCM #ACC25 Lots of new data here including early vs delayed start, multiple evaluations, and mitral regurgitation assessment #cardiotwitter
2
10
43
Unfortunate to see the ODYSSEY HCM trial not meeting its primary endpoints (KCCQ/pVO2). We will need to understand what drove the outcome here. https://t.co/tJMfYlFPca
#cardiotwitter
4
20
42
In recognition of Doctors' Day, we sent out a call for nominations for doctors across the school who go above & beyond. Nearly 400 faculty members were nominated by their colleagues. ➡️ Featured faculty: https://t.co/UU6Ju9Vhu4
#EmoryDoctorsDay2025 #DoctorsDay #HealthcareHeroes
5
4
51
Star future cardiology fellow Patrick McLean presenting #ACC25 👏🏼👏🏼 #hcm @EmoryMedicine @emoryimchiefs @The_EmoryCard
1
2
24
@hcmsociety will host its annual #HCM meeting in partnership with @AHAScience Friday November 7! (AHA Nov 8-10) ✅ register and get hotel through standard AHA portal ✅ abstracts published in @CircAHA ✅ combined reduced registration for both meetings ⬇️ details / New Orleans
0
8
16
The honor of my career to lead this along with Aaron Baggish and Ben Levine. Experts around the world updating new #guidelines for sports for #athletes with heart disease. Major changes! #SDM #sportscards. Published today! @ACCinTouch @American_Heart
https://t.co/sW0ygI9gCW
6
36
99
Thank you 🙏🏽 everyone for all your messages & texts. We are safe & some of the lucky ones. Home is standing & we are safe People have been asking how to help. Here are some great places to give if you can We gathered what we could & volunteered w/ neighbors in our ‘hood ♥️
21
25
138